Public-registry site landscape for NCT03809481, a Heparin-induced Thrombocytopenia study sponsored by Aspen Global Incorporated. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT03809481 (registry record) |
| Sponsor | Aspen Global Incorporated |
| Condition(s) | Heparin-induced Thrombocytopenia |
| Phase | PHASE3 |
| Listed sites | 35 |
| Site countries | United States, Bosnia and Herzegovina, Canada, France, Germany, Italy, Poland, Russia, Serbia |
Eichor generates a preliminary site-risk snapshot for NCT03809481 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →